Compound Evidence File
#EC-2026-0626
Crystagen
Filed under Peptides. The bureau holds 193 laboratory returns for this compound from 70 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
70 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 10.0 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Dec 2025 | 4 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 10.0 | 10.0 | 8 Feb 2026 | 15 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 24 Dec 2025 | 18 Mar 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 5 Apr 2026 | 13 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 5 May 2026 | 8 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Jun 2026 | 15 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Dec 2025 | 16 Aug 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 19 Mar 2026 | 22 Apr 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 10.0 | 10.0 | 10.0 | 20 Apr 2026 | 9 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Jun 2026 | 3 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 10.0 | 10.0 | 10.0 | 12 Jun 2026 | 23 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 9.9 | 9.9 | 10.0 | 2 Feb 2026 | 27 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Mar 2026 | 2 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Jan 2026 | 23 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 10.0 | 18 Feb 2026 | 4 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 10.0 | 15 Apr 2026 | 6 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 19 May 2026 | 18 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Apr 2026 | 16 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 9.9 | 9 Apr 2026 | 23 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Apr 2026 | 27 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Jan 2026 | 24 Jul 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 9.1 | 8.5 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 1 | 9.1 | 9.1 | 9.1 | 13 Feb 2025 | 13 Feb 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.8 | 6.0 | 9.7 | 24 May 2026 | 24 May 2026 |
| Simple PeptideCASE #VI-2026-0782 | X | 1 | 8.6 | 8.6 | 8.6 | 27 Feb 2025 | 27 Feb 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.4 | 7.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.3 | 7.9 | 8.9 | 24 May 2026 | 24 May 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 8.2 | 8.2 | 8.2 | 16 Mar 2025 | 16 Mar 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 8.1 | 8.1 | 8.1 | 13 Jun 2025 | 13 Jun 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 1 | 8.1 | 8.1 | 8.1 | 9 Jun 2025 | 9 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 3 | 7.9 | 7.5 | 8.8 | 21 May 2026 | 21 May 2026 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 7.9 | 7.9 | 7.9 | 14 Jan 2025 | 14 Jan 2025 |
| LiliPeptideCASE #VI-2026-0695 | X | 13 | 7.8 | 5.1 | 9.8 | 7 May 2025 | 26 Jan 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 3 | 7.7 | 7.2 | 8.2 | 7 May 2025 | 17 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.5 | 7.5 | 7.5 | 27 Feb 2025 | 27 Feb 2025 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 | 24 Apr 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 3 | 7.2 | 6.3 | 7.7 | 20 Jun 2025 | 24 May 2026 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 7.2 | 7.2 | 7.2 | 2 Apr 2025 | 2 Apr 2025 |
| Reta-PeptideCASE #VI-2026-0756 | X | 2 | 7.1 | 7.0 | 7.2 | 2 Apr 2025 | 21 May 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 | 25 Apr 2025 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 | 11 Jun 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 6.9 | 6.9 | 6.9 | 7 May 2025 | 7 May 2025 |
| OupeptideCASE #VI-2026-0435 | X | 11 | 6.7 | 2.7 | 9.9 | 28 Mar 2025 | 25 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 2 | 6.7 | 6.5 | 6.8 | 25 Apr 2025 | 20 May 2026 |
| Peptide CraftersCASE #VI-2026-0994 | X | 2 | 6.6 | 6.2 | 7.0 | 17 Dec 2024 | 26 Jan 2026 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 6.6 | 6.6 | 6.6 | 21 May 2025 | 21 May 2025 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 8 | 6.5 | 4.2 | 8.4 | 8 Jul 2025 | 17 May 2026 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 8 | 6.4 | 4.5 | 9.1 | 21 May 2025 | 24 May 2026 |
| Royal PeptidesCASE #VI-2026-0264 | X | 3 | 6.4 | 4.7 | 7.6 | 13 Jun 2025 | 20 May 2026 |
| Amino AmigosCASE #VI-2026-0061 | X | 2 | 6.4 | 5.2 | 7.6 | 2 Apr 2025 | 24 May 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 6.4 | 6.4 | 6.4 | 27 Feb 2025 | 27 Feb 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 6.4 | 6.4 | 6.4 | 13 Feb 2025 | 13 Feb 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 6.3 | 6.3 | 6.3 | 11 Jun 2025 | 11 Jun 2025 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 2 | 6.1 | 3.8 | 8.3 | 8 Jul 2025 | 19 Jan 2026 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 6.0 | 6.0 | 6.0 | 11 Jun 2025 | 11 Jun 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 3 | 5.9 | 4.8 | 7.0 | 11 Jun 2025 | 17 May 2026 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 | 8 Jul 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 5.5 | 5.5 | 5.5 | 9 Jun 2025 | 9 Jun 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 4.5 | 4.5 | 4.5 | 3 Jul 2025 | 3 Jul 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 4.4 | 4.4 | 4.4 | 13 Jun 2025 | 13 Jun 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 3.6 | 3.6 | 3.6 | 9 Jun 2025 | 9 Jun 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 3.1 | 3.1 | 3.1 | 24 Apr 2025 | 24 Apr 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 2.3 | 2.3 | 2.3 | 9 Jun 2025 | 9 Jun 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 2.1 | 2.1 | 2.1 | 25 Apr 2025 | 25 Apr 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 1.6 | 1.6 | 1.6 | 28 Mar 2025 | 28 Mar 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.0 | 0.0 | 0.0 | 8 Jul 2025 | 8 Jul 2025 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jun 2025 | 3 Jun 2025 |
Open any subject to view the batch-level evidence for Crystagen alone.